Author details

Full Name

Mitsuo Iwadate

Affiliation

ORCID

Career Start Year

1998

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
32313085	Author Correction: Development of a novel anti-hepatitis B virus agent via Sp1.	Scientific Reports	2020
31913341	Development of a novel anti-hepatitis B virus agent via Sp1.	Scientific Reports	2020
31863054	A prospective compound screening contest identified broader inhibitors for Sirtuin 1.	Sci Rep	2019
27998820	Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B.	Clinical Microbiology and Infection	2017
28931921	An iterative compound screening contest method for identifying target protein inhibitors using the tyrosine-protein kinase Yes.	Sci Rep	2017
27534621	SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer.	BMC Medical Genomics	2016
27581644	Molecular Dynamics Simulations to Determine the Structure and Dynamics of Hepatitis B Virus Capsid Bound to a Novel Anti-viral Drug.	Chemical and Pharmaceutical Bulletin	2016
26607293	Identification of potential inhibitors based on compound proposal contest: Tyrosine-protein kinase Yes as a target.	Sci Rep	2015
25925353	Principal component analysis-based unsupervised feature extraction applied to in silico drug discovery for posttraumatic stress disorder-mediated heart disease.	BMC Bioinformatics	2015
25446116	Discovering novel direct acting antiviral agents for HBV using in silico screening.	Biochemical and Biophysical Research Communications	2015
26095852	Development of novel hepatitis B virus capsid inhibitor using in silico screening.	Biochemical and Biophysical Research Communications	2015
24565165	Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets.	BMC Systems Biology	2014
25521548	TINAGL1 and B3GALNT1 are potential therapy target genes to suppress metastasis in non-small cell lung cancer.	BMC Genomics	2014
23855671	Bioinformatic screening of autoimmune disease genes and protein structure prediction with FAMS for drug discovery.	Protein and Peptide Letters	2014
23843247	Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions.	Proteins	2013
20045957	Method for predicting homology modeling accuracy from amino acid sequence alignment: the power function.	Chemical and Pharmaceutical Bulletin	2010
20045969	HUMAN FAMSD-BASE: high quality protein structure model database for the human genome using the FAMSD homology modeling method.	Chemical and Pharmaceutical Bulletin	2010
19952440	FAMSD: A powerful protein modeling platform that combines alignment methods, homology modeling, 3D structure quality estimation and molecular dynamics.	Chemical and Pharmaceutical Bulletin	2009
18451572	Bioinformatics based Ligand-Docking and in-silico screening.	Chemical and Pharmaceutical Bulletin	2008
17894329	Fams-ace: a combined method to select the best model after remodeling all server models.	Proteins: Structure, Function and Bioinformatics	2007
17853449	The SKE-DOCK server and human teams based on a combined method of shape complementarity and free energy estimation.	Proteins: Structure, Function and Bioinformatics	2007
16187353	Protein structure prediction in CASP6 using CHIMERA and FAMS.	Proteins: Structure, Function and Bioinformatics	2005
15133227	Evaluation of homology modeling of the severe acute respiratory syndrome (SARS) coronavirus main protease for structure based drug design.	Chemical and Pharmaceutical Bulletin	2004
18428727	FAMS and FAMSBASE for protein structure.	Current Protocols in Bioinformatics	2004
14563640	Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.	Blood	2004
12784361	Evaluation of the third solvent clusters fitting procedure for the prediction of protein-protein interactions based on the results at the CAPRI blind docking study.	Proteins: Structure, Function and Bioinformatics	2003
12520053	Enlarged FAMSBASE: protein 3D structure models of genome sequences for 41 species.	Nucleic Acids Research	2003
11168364	Interaction of mastoparan with membranes studied by 1H-NMR spectroscopy in detergent micelles and by solid-state 2H-NMR and 15N-NMR spectroscopy in oriented lipid bilayers.	Eur J Biochem	2001
11256808	Pressure-dependent changes in the structure of the melittin alpha-helix determined by NMR.	J Biomol NMR	2001
10880974	Structure determination of [Arg8]vasopressin methylenedithioether in dimethylsulfoxide using NMR.	Eur J Biochem	2000
10342761	Structural analysis of silk with 13C NMR chemical shift contour plots.	Int J Biol Macromol	1999
10406639	Solid phase synthesis and biological activities of [Arg8]-vasopressin methylenedithioether.	Bioorg Med Chem Lett	1999
10212983	C alpha and C beta carbon-13 chemical shifts in proteins from an empirical database.	J Biomol NMR	1999
9826196	The structure of the melittin tetramer at different temperatures--an NOE-based calculation with chemical shift refinement.	Eur J Biochem	1998